Chemistry Wealth Management’s Palantir PLTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$389K Hold
3,337
0.06% 150
2026
Q1
$488K Sell
3,337
-8,765
-72% -$1.34M 0.09% 123
2025
Q4
$2.15M Sell
12,102
-1,074
-8% -$194K 0.4% 41
2025
Q3
$2.4M Sell
13,176
-1,551
-11% -$251K 0.46% 35
2025
Q2
$2.01M Sell
14,727
-1,874
-11% -$220K 0.43% 38
2025
Q1
$1.4M Sell
16,601
-542
-3% -$47.6K 0.33% 48
2024
Q4
$1.3M Sell
17,143
-1,687
-9% -$98.3K 0.3% 52
2024
Q3
$700K Buy
18,830
+3,529
+23% +$108K 0.17% 83
2024
Q2
$388K Sell
15,301
-1,380
-8% -$31.1K 0.1% 108
2024
Q1
$384K Sell
16,681
-880
-5% -$18.8K 0.1% 111
2023
Q4
$302K Buy
17,561
+300
+2% +$5.34K 0.09% 128
2023
Q3
$276K Sell
17,261
-33
-0.2% -$526 0.09% 128
2023
Q2
$265K Hold
17,294
0.09% 128
2023
Q1
$146K Buy
+17,294
New +$135K 0.05% 139
2022
Q4
Sell
-19,309
Closed -$157K 143
2022
Q3
$157K Buy
19,309
+1,520
+9% +$13.5K 0.06% 128
2022
Q2
$161K Buy
+17,789
New +$176K 0.06% 131

Other funds holding PLTR

Chemistry Wealth Management's PLTR Position: Q2 2026 in Review

Chemistry Wealth Management held its Palantir (PLTR) position steady in Q2 2026 at 3,337 shares worth $389K. The position accounts for 0.06% of the portfolio, ranked #150.

Chemistry Wealth Management first reported a position in PLTR in Q2 2022 and has held it in 16 quarters since. The position peaked at $2.4M in Q3 2025. 1,375 funds tracked by Wall St. Rank hold PLTR as of Q2 2026.

  • Chemistry Wealth Management held 3,337 shares of Palantir worth $389K as of Q2 2026.
  • Chemistry Wealth Management left its Palantir share count unchanged in Q2 2026.
  • Palantir made up 0.06% of Chemistry Wealth Management's portfolio in Q2 2026, its #150 holding.
  • Chemistry Wealth Management first reported a position in Palantir in Q2 2022 and has held it in 16 quarters since.
  • Chemistry Wealth Management's Palantir position peaked at $2.4M in Q3 2025.
  • 1,375 funds tracked by Wall St. Rank held Palantir as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.